EDITOR’S NOTES


What Galileo Saw—and the Challenges of Being Forward-Looking in Healthcare


By Mark Hagland One of the most fascinating life-journeys in the


history of science is that of Galileo Galilei (1564-1642), the Italian scientist who challenged the received wisdom of his time, and for his pioneering work, was shut down by the Inquisition, which forced him to recant his scientifi c fi ndings and go silent at the height of his powers. As Mario Livio notes in his 2020 book Galileo and


the Science Deniers, “Galileo’s journey as a scientist started in 1583, when he…began to study mathemat- ics. By 1590, at the age of twenty-six, he already had the audacity to criticize the teachings on motion of the great Greek philosopher Aristotle, according to which things moved because of a built-in impetus.” Yet, Livio notes, “In spite of his personal disagree-


Mark Hagland


ments with some orthodox church dicta, as late as May 18, 1630, Galileo was still received in Rome as an honored guest by Pope Urban VIII, and he left the


city under the impression that the Pope had approved the printing of his book Dialogue Concerning the Two Chief World Systems… Overestimating the strength of his friendship with the pontiff and underestimating the fragility of the delicate psychological and political position of the Pope in that turbulent post-Reformation era, Galileo continued to believe that reason would prevail. ‘Facts, which at fi rst seem improbable, will, even on scant explanation, drop the cloak which has hidden them and stand forth in naked and simple beauty,’ he once wrote.” Well, as it turns out, after the book was published in 1632, with its argument for


heliocentrism—that the Earth revolved around the Sun and not vice-versa—the full weight of the Roman Inquisition crashed down on Galileo and, essentially threatened with his life, he was forced to recant the fact-based science he had pioneered, allegedly uttering under his breath the famous phrase “Eppure si muove”—“and yet it [the earth] does move.” Still, it would be reductive to view Galileo as someone divorced from the realities of


the time and place in which he lived and worked. Indeed, Alison Abbott, in a September 2018 article published in Nature, wrote about the discovery that Galileo had initially tried to hedge on some of his statements, even before the Inquisition pounced on him. Abbott writes that “The seven-page letter, written to a friend on 21 December 1613 and signed ‘G.G.,’ provides the strongest evidence yet that, at the start of his battle with the religious authorities, Galileo actively engaged in damage control and tried to spread a toned-down version of his claims.” Galileo was a thought leader at a time and in a place where thought leadership


was simply not welcomed. But what about now? The U.S. healthcare delivery system is in the midst of profound upheaval right now, both because of the huge disruption imposed on it by the COVID-19 pandemic; but also because that pandemic hit the delivery system at a time when the strategic and operational landscape of healthcare was already changing. This is no time for delicate constitutions; indeed, it’s clear that the senior leaders who are most willing to take intelligent risks and move forward into the uncharted future, are those who will end up leading their organizations forward into market leadership and longer-term success. All those interviewed for this issue’s cover story (p. 4) speak to the challenges and opportunities involved in this unprecedented moment. And those most willing to lead, will be able to relate pretty well, I think, to “Eppure si muove.” They know that being on the right side of history means being bold—now as in the 17th


century. 2 hcinnovationgroup.com | NOVEMBER/DECEMBER 2020


www.HCinnovationgroup.com EDITORIAL


Editor-in-Chief: Mark Hagland 917-275-2426


mhagland@HCinnovationgroup.com


Managing Editor: Rajiv Leventhal 212-812-1418


rleventhal@HCinnovationgroup.com


Senior Editor: David Raths draths@mac.com


ADVERTISING SALES


Publisher: Matt Raynor 561-776-0015


mraynor@HCinnovationgroup.com


Sales Director: Anita Brodersen 847-744-2884


abrodersen@HCinnovationgroup.com


Sales Director: Steve Menc 814-450-5571


smenc@HCinnovationgroup.com


Events Program Director: Stephen McCollum smccollum@HCinnovationgroup.com SERVICES


Graphic Artist: Patti Connors


Ad Traffi c Manager: Tiffany Coffman tcoffman@endeavorb2b.com


Sr. Client Relationship Manager: Casie McAllister cmcallister@hcinnovationgroup.com


eProduct Coordinator: Mary Haberstroh mhaberstroh@endeavorb2b.com


List Rentals/Ad Contracts Mgr: Laura Moulton lmoulton@endeavorb2b.com


Single Back Issues/Subscriptions: subscriptions@endeavorb2b.com GROUP PUBLISHER


Amy Mularski EVP, Healthcare Group amularski@HCinnovationgroup.com


CORPORATE TEAM


CEO Chris Ferrell


CRO/CMO June Griffin CFO William Nurthen COO Patrick Rains


Chief Administrative and Legal Officer Tracy Kane EVP Special Projects Kristine Russell EVP Key Accounts Scott Bieda


331 54th Ave N., Nashville, TN 37209 Phone: (941) 388-7050 Fax: (941) 388-7490 www.HCinnovationGroup.com


Healthcare Innovation content is also available from PROQUEST Information and Learning, 300 N. Zeeb Road, Ann Arbor, MI 48106 USA, 313-761-4700. Copyright Clearance Center, Inc. 978-750-8400.


Publishers of this magazine assume no responsibility for statements made by their advertisers in business competition, nor do they assume responsibility for statements/opinions expressed or implied in the columns of this magazine. Printed in the USA.


HEALTHCARE INNOVATION formerly Health Management Technology


(ISSN 2641-7502)


Published bi-monthly by Endeavor Business Media, LLC., 2477 Stickney Point Rd., Suite 221B Sarasota, FL 34231, (941) 388-7050.


Subscription rates: $52.80 per year in the United States; $64.90 Canada/ Mexico; International subscriptions are $95.15 per year. Current single copies (if available) are $15.40 each (U.S), and $19.80 each (international). Back is- sues (if available) are $17.60 each (U.S.) and $22 each (International). Payment must be made in U.S. funds on a branch of a U.S. bank within the continental United States and accompany request. Subscription inquiries: subscriptions@ endeavorb2b.com.


Title registered U.S. Patent Offi ce. Copyright 2019 by Endeavor Business Media, LLC., All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, includ- ing photocopy, recording, or any information storage-and-retrieval system, without permission in writing from the publisher.


Offi ce of publication: Periodicals Postage Paid at Nashville, TN 37209 and at additional mailing offi ces. Postmaster: Send address changes to Omeda (Healthcare Innovation), PO Box 3257, Northbrook, IL 60065-3257.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32